SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Turitz Andrew
(Last) (First) (Middle)
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
(Street)
PURCHASE NY 10577
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP - BUSINESS DEVELOPMENT
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/02/2022 M 1,205 A (1) 8,761 D
Common Stock 03/02/2022 M 2,050 A (2) 10,811 D
Common Stock 03/02/2022 M 515 A (2) 11,326 D
Common Stock 03/02/2022 M 1,147 A (1) 12,473 D
Common Stock 03/02/2022 M 868 A (2) 13,341 D
Common Stock 03/03/2022 S 1,754(3) D $70.239 11,587 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/02/2022 M 1,205 (4) (4) Common Stock 1,205 $0 1,205 D
Performance Stock Units (2) 03/02/2022 M 2,050 (5) (5) Common Stock 2,050 $0 2,048 D
Performance Stock Units (6) 03/02/2022 A 1,030(7) (8) (8) Common Stock 1,030 $0 1,030 D
Performance Stock Units (2) 03/02/2022 M 515 (9) (9) Common Stock 515 $0 515 D
Restricted Stock Units (1) 03/02/2022 M 1,147 (10) (10) Common Stock 1,147 $0 2,295 D
Performance Stock Units (6) 03/02/2022 A 2,602(11) (12) (12) Common Stock 2,602 $0 2,602 D
Performance Stock Units (2) 03/02/2022 M 868 (13) (13) Common Stock 868 $0 1,734 D
Explanation of Responses:
1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
4. On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
5. On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
6. Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
7. Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021.
8. The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022.
9. On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
10. On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
11. Performance award amount determined based on metrics in respect of the issuer's 2021 financial results
12. The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022.
13. On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
/s/ Adam C. Vandervoort, Attorney-in-Fact 03/04/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.